ArticleScientific reports2025

Efficacy and safety of neoadjuvant therapy with tislelizumab plus axitinib for nonmetastatic renal cell carcinoma with inferior vena cava tumor thrombus: a retrospective study.

Zhongjie Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.